Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies.
about
Prospects for vaccine prevention of meningococcal infectionDevelopment and use of a serum bactericidal assay using pooled human complement to assess responses to a meningococcal group A conjugate vaccine in African toddlers.Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008Direct and rapid identification and genogrouping of meningococci and porA amplification by LightCycler PCR.Streptococcus pneumoniae serotype 1 burden in the African meningitis belt: exploration of functionality in specific antibodiesMeningococcal group C conjugate vaccines.Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice.A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis BeltAntibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2-29 Years.Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac.Persistence of antibodies in laboratory staff immunized with quadrivalent meningococcal polysaccharide vaccine.Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlersSeroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era.Relation between structure and immunologic properties of the Vi capsular polysaccharide.Immunogenicity of meningococcal ACYW135 polysaccharide vaccine in Saudi children 5 to 9 years of age.Polysaccharide-protein conjugate vaccination induces antibody production but not sustained B-cell memory in the human nasopharyngeal mucosa.KfoA, the UDP-glucose-4-epimerase of Escherichia coli strain O5:K4:H4, shows preference for acetylated substrates.
P2860
Q24537338-7A854A99-6DD7-4C9E-AE8A-1FBE5383980EQ33601899-A9C59DBA-E270-4426-ABAB-8A51D4AF9596Q34606343-1D01EA82-7F5C-4DFA-9E6D-A3098F6456E0Q34989430-0BA21EFE-5617-41AC-81D3-A7D3A4119B8DQ35221191-B035142F-2FA6-42FC-A81E-7A6D65FE2903Q35269816-A0D8660A-0BE8-447D-AC88-105F18EB7392Q35801994-8B207964-C21E-40D8-84E7-0F7FC45D6C25Q35922578-AF09C612-4D96-4E76-9802-7399D91CB24FQ36265032-9EEBAF4E-E40F-4A7D-8D98-0980DAB8063AQ36265075-78AC3E24-EA12-4496-82D3-42677DCCED1CQ36689674-0BDEC1B7-97A1-45C9-BC3B-8969624AE116Q36849834-12020ACB-3528-45E5-946C-82526D818374Q36974336-8F2E68CE-C2BD-4EFF-A821-3FE3F1AC6F21Q36990350-DC4FB288-3D9C-48F9-8401-8A1FAB4E629CQ42082720-42DE1095-0D48-4DE4-BE33-8950703C2D65Q43876810-B475A880-9967-469F-9B6B-DE02763CFB47Q47328575-7871D3E8-7A10-42E6-B672-B714F818DA5B
P2860
Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies.
description
1985 nî lūn-bûn
@nan
1985 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Escherichia coli K51 and K93 c ...... , and epidemiological studies.
@ast
Escherichia coli K51 and K93 c ...... , and epidemiological studies.
@en
type
label
Escherichia coli K51 and K93 c ...... , and epidemiological studies.
@ast
Escherichia coli K51 and K93 c ...... , and epidemiological studies.
@en
prefLabel
Escherichia coli K51 and K93 c ...... , and epidemiological studies.
@ast
Escherichia coli K51 and K93 c ...... , and epidemiological studies.
@en
P2093
P2860
P356
P1476
Escherichia coli K51 and K93 c ...... , and epidemiological studies.
@en
P2093
Guirguis N
Robbins JB
Schneerson R
Shiloach J
el Kholy A
P2860
P304
P356
10.1084/JEM.162.6.1837
P407
P577
1985-12-01T00:00:00Z